Omnix 50 Dry Syrup contains Cefixime 50mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, otitis media, pharyngitis, tonsillitis, and uncomplicated gonorrhea caused by susceptible strains of bacteria. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Omnix 50 Dry Syrup is formulated for oral administration, providing an easy-to-use option for pediatric and adult patients who have difficulty swallowing tablets. The dry syrup form ensures accurate dosing and improved compliance in children. It is important to reconstitute the powder with the specified amount of water before administration and to shake well prior to each use. The dosage and duration of therapy should be determined by a healthcare professional based on the severity of infection and patient-specific factors. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Hypersensitivity reactions, although rare, may occur in patients with a history of penicillin or cephalosporin allergy. Omnix 50 Dry Syrup should be used with caution in patients with renal impairment and is contraindicated in those with known hypersensitivity to cefixime or other cephalosporins.